Cycle Pharmaceuticals is a pioneering pharmaceutical company, reimagining how drugs can benefit patients, to make their lives easier and improve their quality of life at every stage.
Cycle has three core areas of pharmaceutical development:
- improving drugs – optimizing an existing drug;
- repurposing drugs – creating a new indication for an already existing drug;
- generics – reinstating generic drugs, previously available in the market.
These three areas of focus are underpinned by formulation technology – creating new drug delivery technologies to improve the efficacy and effectiveness of drugs, allowing Cycle to give patients greater freedom and choice.
With Headquarters in Cambridge (UK) and offices in Boston, Massachusetts (USA), Cycle has developed unique partnerships with the University of Cambridge and other renowned universities around the world. Cycle is not limited to any one disease area. The company is actively working in a broad range of disease areas, from cardiovascular and inflammatory conditions, to rare diseases such as cystic fibrosis and tyrosinemia type 1 (HT-1).